NUEVOLUTION A/S: Financial statements 2025
CVR: 26029708
Source: annual report 2025, Danish Business Authority
01/01/2025 – 31/12/2025
NUEVOLUTION A/S (CVR 26029708) has filed annual accounts for 2025. In 2025, the company reported revenue of DKK 203,323,000 and a net result of DKK 39,754,000 compared with DKK -18,383,000 the year before. That is an increase of 71.7% compared with the year before. The profit margin was 19.6%. Equity in the 2025 report amounted to DKK 89,493,000. The solvency ratio was 37.6%. The company had 80 employees in the financial year.
- Revenue
- DKK 203,323,000
- Profit/Loss
- DKK 39,754,000
- Equity
- DKK 89,493,000
- Total Assets
- DKK 238,040,000
- Employees
- 80
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2025 | 203.3 mio. | - | 39.8 mio. | 89.5 mio. | 80 |
| 2024 | 118.4 mio. | - | -18.4 mio. | 49.7 mio. | 77 |
| 2023 | 77.2 mio. | - | -36.2 mio. | 68.1 mio. | 69 |
| 2022 | 68.5 mio. | - | -28.1 mio. | 104.3 mio. | 63 |
| 2021 | 162.3 mio. | - | 63 mio. | 132.4 mio. | 56 |
Official annual report
How creditworthy is NUEVOLUTION A/S?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2025
As of December 2, 2025, Omari Clinton Wise has joined the board of directors of NUEVOLUTION A/S.
As of November 14, 2025, Adam Stewart Elinoff has left the board of directors of NUEVOLUTION A/S.
As of October 8, 2025, Jeffrey David Bernd has joined the board of directors of NUEVOLUTION A/S.
As of October 8, 2025, Adam Stewart Elinoff has joined the board of directors of NUEVOLUTION A/S.
As of October 8, 2025, Mikkel Kaasgaard Rasmussen has left the board of directors of NUEVOLUTION A/S.
As of October 8, 2025, Filippo Montano has left the board of directors of NUEVOLUTION A/S.
NUEVOLUTION A/S has published its annual report for 2024. Revenue came to DKK 118,442,000, and the net result was DKK -18,383,000.
About NUEVOLUTION A/S
NUEVOLUTION A/S is a Danish company of the type Aktieselskab based in København Ø, founded in 2001. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company was previously named CHEMGENE ApS. The management consists of Thomas Franch. The board consists of Tore von Würden Petersen (chair), Jeffrey David Bernd and Omari Clinton Wise. The company is owned by Amgen, Inc.. The company has 59 employees (2018). In 2025, the company reported revenue of DKK 203,323,000 and a net result of DKK 39,754,000 compared with DKK -18,383,000 the year before. Equity in the 2025 report amounted to DKK 89,493,000.